Delivery Order SPE2DB22D2211-SPE2DB24FMXG9
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp's Corporate Office Division a delivery order contract worth $2,128.13 for the supply of TRELEGY ELLIPTA 100-62.5-25 60S pharmaceutical products. The award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The $2,961.48 contract is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a specialty pharmaceutical product. The award does not have a set-aside designation. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued at up to $999,999,999.00, which serves...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a $3,513.89 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of TRELEGY ELLIPTA 100-62.5-25 60S pharmaceutical products. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp to provide a comprehensive range of pharmaceutical products and medical supplies in support of...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,681,115 units of the pharmaceutical product TRELEGY ELLIPTA 200-62.5-25 60S. The contract has a potential value of $56,238.08 and a completion date of February 16, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor for this delivery order, which does not have a set-aside...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract valued at $47,949.34 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Trelegy Ellipta 100-62.5-25 60S, a pharmaceutical product. This Delivery Order is associated with a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by Cencora, Inc. (doing business as AmerisourceBergen) with the DLA Troop Support Medical. The IDC serves...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TRELEGY ELLIPTA 100-62.5-25 60S, a specialty pharmaceutical product. The contract has a potential value of $3,138.17 and a completion date of March 4, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor and will be delivering the pharmaceutical product from its corporate...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $6,068.70 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of TRELEGY ELLIPTA 200-62.5-25 60S pharmaceutical products. This delivery order contract has an ultimate completion date of April 12, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,249.97 contract is for the delivery of Trelegy Ellipta 200-62.5-25 60S, a specialty pharmaceutical product, to support military treatment programs and facilities. This delivery order is issued under a larger $999,999,999.00 indefinite delivery contract (IDC) held by...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $5,119.81 to AmerisourceBergen Drug Corp, Corporate Office Division, for the pharmaceutical product Trelegy Ellipta 100-62.5-25 60s. This contract has no set-aside designation and has an ultimate completion date of September 19, 2024. AmerisourceBergen is a leading pharmaceutical distributor that provides a wide range of essential medical commodities, including prescription medications, vaccines,...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, is a firm fixed price delivery order for the pharmaceutical product Trelegy Ellipta 100-62.5-25 60S. The $11,144.01 award was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense, and has an ultimate completion date of April 1, 2024. Amerisourcebergen Drug Corp serves as the prime contractor, with...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB24FMXG9Delivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order valued at $2,999.56 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The delivery order is for the supply of the pharmaceutical product Trelegy Ellipta 200-62.5-25 60S. This award is part of Amerisourcebergen Drug Corp's prime contract with DLA, an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary vehicle for Amerisourcebergen to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 2/28/24 |